New
AI & RoboticsMore in AI & Robotics→
J&J unveils Ottava robot after FDA de novo authorization
Key Takeaways
- Ottava has four robotic arms integrated into the operating table and can reduce OR footprint by 30% to 50%, according to J&J.
- The system includes instrument redesigns aimed at common surgeon complaints involving suturing and scissor performance.
- FDA de novo authorization moves Ottava from a long development cycle into the commercial and clinical adoption phase.
DE
DT Editorial Team··via therobotreport.com